Accès ouvert
2026
article
OpenAlex
Shruti Sanjay Salunkhe, Jenny Nater, Colleen Schweitzer, Daqin Mao et autres
Axicabtagene ciloleucel (axi-cel) and brexucabtagene autoleucel (brexu-cel) are autologous anti-CD19 chimeric antigen receptor (CAR) T cell products originally approved in the pivotal ZUMA-1 and ZUMA-2 clinical studies for the treatment of relapsed/refractory (r/r) large B cell lymphoma (r/r LBCL) and r/r mantle …
au
(code pays fourni par la source)
2025
article
OpenAlex
Qingyang Zhang, Zixing Wang, Allen Xue, James B. Whitmore
Cancer immunotherapy trials often present unique challenges for time-to-event data modeling and analysis due to heterogeneous treatment effects across time or subgroups. A few known scenarios are delayed treatment effects and cure rates, where survival and hazard functions often take complex shapes. …
Accès ouvert
2025
article
OpenAlex
Allen Xue, Hao Liu, Zhen Wang, Gaojian Tao et autres
Study DesignCase-control Study.ObjectiveTo evaluate the alterations in lumbar stabilizing muscles, particularly the erector spinae (ES), lumbar multifidus (LM), and gluteus maximus (Gmax), and their association with dynamic sagittal imbalance (DSI) after ambulation.MethodsThis study included patients with low back pain and anterior trunk …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Hugo Muñoz-Hernández, Yixin Xu, Aitor Pellicer Camardiel, Daniel X. Zhang et autres
The γ-tubulin ring complex (γ-TuRC) is an essential multiprotein assembly that provides a template for microtubule nucleation. The γ-TuRC is recruited to microtubule-organizing centers (MTOCs) by the evolutionarily conserved attachment factor NEDD1. However, the structural basis of the NEDD1-γ-TuRC interaction is not …
ch, ru, us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Hugo Muñoz-Hernández, Yixin Xu, Daniel Y. Zhang, Allen Xue et autres
Summary The γ-tubulin ring complex (γ-TuRC) is an essential multiprotein assembly, in which γ-tubulin, GCP2-6, actin, MZT1 and MZT2 form an asymmetric cone-shaped structure that provides a template for microtubule nucleation. The γ-TuRC is recruited to microtubule organizing centers (MTOCs), such as …
ch, us
(code pays fourni par la source)
2024
other
OpenAlex
S. J. Zhao, Allen Xue, Yi Li, Jingyu Chen et autres
It suggests that robot-assisted pedicle screw placement in posterior surgery for patients with ADS can significantly improve the accuracy of screw placement and reduce the incidence of facet joint violation.
cn, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Amol Aher, L. Urnavicius, Allen Xue, Kasahun Neselu et autres
us
(code pays fourni par la source)
2023
article
OpenAlex
Zixing Wang, Qingyang Zhang, Allen Xue, James B. Whitmore
With the advent of cancer immunotherapy, some special features including delayed treatment effect, cure rate, diminishing treatment effect and crossing survival are often observed in survival analysis. They violate the proportional hazard model assumption and pose a unique challenge for the conventional …
us
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Amol Aher, L. Urnavicius, Allen Xue, Kasahun Neselu et autres
Microtubules are composed of α/β-tubulin dimers positioned head-to-tail to form protofilaments that associate laterally in varying numbers. It is not known how cellular microtubules assemble with the canonical 13-protofilament architecture, resulting in micrometer-scale α/β-tubulin tracks for intracellular transport that align with, rather …
us
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Anik R. Patel, Mark Ray, Yael Rodríguez‐Guadarrama, Nathaniel Smith et autres
Introduction: ZUMA-7 is the largest randomized controlled trial (RCT) for chimeric antigen receptor (CAR) T-cell therapy which compared axicabtagene ciloleucel (Axi-cel) to standard of care (SoC) including autologous stem cell transplant (ASCT) for the treatment of relapsed or refractory DLBCL. Both arms …
2023
conference-abstract
OpenAlex
Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos et autres
Background: Axi-cel is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL). Long-term results from ZUMA-1, a multicenter, single-arm, Phase 1/2 study of axi-cel in patients with refractory LBCL, demonstrated …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jason R. Westin, Caron A. Jacobson, Julio C. Chávez, Anna Sureda et autres
Topic: 19. Aggressive Non-Hodgkin lymphoma - Clinical Background: The nearly 40% of patients with large B-cell lymphoma (LBCL) who are refractory to or relapse after current first-line standard-of-care (SOC) regimens, such as R-CHOP (rituximab [R] + cyclophosphamide [C], doxorubicin [H], vincristine [O], …
us, es, fr, de, au, gb, nl
(code pays fourni par la source)